Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1H-Benzo[f]Chromene Moieties and Analysis of Their Antitumor Mechanisms
暂无分享,去创建一个
Lu Jin | T. Syrovets | T. Simmet | A. El-Agrody | A. Fouda | H. M. Mohamed | M. Elgaafary | Abdelaaty Hamed | J. Ulrich | H. El-Mawgoud
[1] T. Syrovets,et al. Synthesis, Cytotoxic Activity, Crystal Structure, DFT Studies and Molecular Docking of 3-Amino-1-(2,5-dichlorophenyl)-8-methoxy-1H-benzo[f]chromene-2-carbonitrile , 2021, Crystals.
[2] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[3] Thomas . Hobbes,et al. Cn , 2020, Catalysis from A to Z.
[4] M. Shaaban,et al. Synthesis of novel feruloyl dipeptides with proapoptotic potential against different cancer cell lines. , 2020, Bioorganic chemistry.
[5] A. El-Agrody,et al. A proficient microwave synthesis with structure elucidation and the exploitation of the biological behavior of the newly halogenated 3-amino-1H-benzo[f]chromene molecules, targeting dual inhibition of topoisomerase II and microtubules. , 2019, Bioorganic chemistry.
[6] A. El-Agrody,et al. Microwave synthesis of novel halogenated β-enaminonitriles linked 9-bromo-1H-benzo[f]chromene moieties: Induces cell cycle arrest and apoptosis in human cancer cells via dual inhibition of topoisomerase I and II. , 2019, Bioorganic chemistry.
[7] Lu Jin,et al. A Novel Polyhalogenated Monoterpene Induces Cell Cycle Arrest and Apoptosis in Breast Cancer Cells , 2019, Marine drugs.
[8] Sung-Bae Kim,et al. How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies , 2018, ESMO Open.
[9] Hany E. A. Ahmed,et al. Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect , 2018, Journal of enzyme inhibition and medicinal chemistry.
[10] A. Pichlmair,et al. Oxeiptosis – a ROS induced caspase-independent apoptosis-like cell death pathway , 2017, Nature Immunology.
[11] A. Amr,et al. Synthesis, X-ray Characterization and Antimicrobial Activity of 3-Amino-1-(2,4-dichlorophenyl)-8-Methoxy-1H-Benzo[f]Chromene-2-Carbonitrile , 2017 .
[12] S. Ezzat,et al. Acovenoside A Induces Mitotic Catastrophe Followed by Apoptosis in Non-Small-Cell Lung Cancer Cells. , 2017, Journal of natural products.
[13] A. Amr,et al. X-ray Characterizations of New Synthesized 3-Amino-1-(2,6-difluorophenyl)-8-Methoxy-1H-Benzo[f]Chromene-2-Carbonitrile , 2017 .
[14] A. Amr,et al. X-ray, Microwave Assisted Synthesis and Spectral Data of 3-Amino-1-(3,5-dibromo-2-methoxy phenyl)-8-methoxy-1H-benzo[f]chromene-2-carbonitrile , 2017 .
[15] J. Ilaš,et al. Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents , 2017, EXCLI journal.
[16] S. Maddila,et al. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives. , 2017, Anti-cancer agents in medicinal chemistry.
[17] A. El-Agrody,et al. Halogenated 2-amino-4H-benzo[h]chromene derivatives as antitumor agents and the relationship between lipophilicity and antitumor activity , 2017, Medicinal Chemistry Research.
[18] A. El-Agrody,et al. Synthesis, in-vitro cytotoxicity of 4H-benzo[h]chromene derivatives and structure—activity relationships of 4-aryl group and 3-, 7-positions , 2016, Chemical Papers.
[19] A. Brito,et al. Biological importance of structurally diversified chromenes. , 2016, European journal of medicinal chemistry.
[20] P. Sorger,et al. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.
[21] A. El-Agrody,et al. Synthesis, Biological Evaluation and Molecular Docking Studies of 4Hbenzo[ h]chromenes, 7H-benzo[h]chromeno[2,3-d]pyrimidines as Antitumor Agents , 2015 .
[22] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[23] T. Syrovets,et al. An α-Acetoxy-Tirucallic Acid Isomer Inhibits Akt/mTOR Signaling and Induces Oxidative Stress in Prostate Cancer Cells , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[24] M. Naimi-Jamal,et al. Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.
[25] A. El-Agrody,et al. Studies on the synthesis, in vitro antitumor activity of 4H-benzo[h]chromene, 7H-benzo[h]chromene[2,3-d]pyrimidine derivatives and structure–activity relationships of the 2-,3- and 2,3-positions , 2014, Medicinal Chemistry Research.
[26] Duane D. Miller,et al. Chromenes: potential new chemotherapeutic agents for cancer. , 2013, Future medicinal chemistry.
[27] A. Fojo,et al. Phase I/II trial of crolibulin and cisplatin in solid tumors with a focus on anaplastic thyroid cancer: Phase I results. , 2013 .
[28] A. El-Agrody,et al. Synthesis, antitumor activity of 2-amino-4H-benzo[h]chromene derivatives, and structure–activity relationships of the 3- and 4-positions , 2013, Medicinal Chemistry Research.
[29] D. Green,et al. Mitochondria and cell signalling , 2012, Journal of Cell Science.
[30] Hanamant Jadhav,et al. Studies on synthesis , 2011 .
[31] L. Bernstein,et al. Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] L. Carey,et al. Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.
[33] R. Youle,et al. The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.
[34] Peng Huang,et al. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.
[35] C. Xing,et al. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. , 2006, Journal of medicinal chemistry.
[36] B. Cookson,et al. Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.
[37] L. Qiu,et al. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. , 2004, Molecular cancer therapeutics.
[38] D. Green,et al. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis , 2003, The Journal of cell biology.
[39] Helen J. Mitchell,et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans , 2000 .
[40] S. Srinivasula,et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] Todd R. Wiernicki,et al. Inhibition of mitosis and microtubule function through direct tubulin binding by a novel antiproliferative naphthopyran LY290181. , 1997, Molecular pharmacology.
[42] D. Panda,et al. Suppression of Microtubule Dynamics by LY290181 , 1997, The Journal of Biological Chemistry.
[43] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[44] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[45] A. Halawa,et al. The anti-proliferative activity of novel 4H-benzo[h]chromenes, 7H-benzo[h]-chromeno[2,3-d]pyrimidines and the structure–activity relationships of the 2-, 3-positions and fused rings at the 2, 3-positions , 2017 .
[46] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.